DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions
暂无分享,去创建一个
Joshua C Denny | Wei-Qi Wei | Dan M Roden | Patrick Wu | QiPing Feng | Bingshan Li | Qingxia Chen | Nancy J Cox | Scott D Nelson | Juan Zhao | Cosby A Stone | Eric A Larson | C Michael Stein | Elizabeth J Phillips | D. Roden | J. Denny | Wei-Qi Wei | Qingxia Chen | Bingshan Li | Q. Feng | C. Stein | Patrick Wu | Eric A. Larson | E. Phillips | C. Stone | S. Nelson | Juan Zhao | N. Cox
[1] A. Trivedi,et al. Are non‐allergic drug reactions commonly documented as medication “allergies”? A national cohort of Veterans' admissions from 2000 to 2014 , 2017, Pharmacoepidemiology and drug safety.
[2] E. Phillips,et al. Penicillin Allergy Is Not Necessarily Forever. , 2017, JAMA.
[3] R. Mägi,et al. Genome-wide Study Identifies Association between HLA-B∗55:01 and Self-Reported Penicillin Allergy , 2020, American journal of human genetics.
[4] Jonathan M. Teich,et al. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records , 2012, J. Am. Medical Informatics Assoc..
[5] Olivier Bodenreider,et al. Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support , 2017, J. Am. Medical Informatics Assoc..
[6] Steven J. Steindel,et al. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets , 2010, J. Am. Medical Informatics Assoc..
[7] W. DuMouchel,et al. Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting , 2003, Pharmacoepidemiology and drug safety.
[8] D. Baumgart,et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. , 2020, NPJ digital medicine.
[9] Tal Lorberbaum,et al. Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation. , 2016, Journal of the American College of Cardiology.
[10] L. Goldstein,et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[11] Stuart J. Nelson,et al. Normalized names for clinical drugs: RxNorm at 6 years , 2011, J. Am. Medical Informatics Assoc..
[12] Shiew-Mei Huang,et al. Drug‐Drug, Drug—Dietary Supplement, and Drug—Citrus Fruit and Other Food Interactions: What Have We Learned? , 2004, Journal of clinical pharmacology.
[13] J. Venhorst,et al. Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] Hua Xu,et al. Development and evaluation of an ensemble resource linking medications to their indications , 2013, J. Am. Medical Informatics Assoc..
[15] L J Lesko,et al. Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling , 2007, Clinical pharmacology and therapeutics.
[16] Matthew L. Lenz,et al. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions. , 1995, American journal of hypertension.
[17] R. Collins,et al. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. , 2010, Lancet.
[18] P. Meredith,et al. The combination of prazosin and verapamil in the treatment of essential hypertension , 1988, Clinical pharmacology and therapeutics.
[19] David W. Bates,et al. High-priority drug-drug interactions for use in electronic health records , 2012, J. Am. Medical Informatics Assoc..
[20] D. Roden,et al. Development of a Large‐Scale De‐Identified DNA Biobank to Enable Personalized Medicine , 2008, Clinical pharmacology and therapeutics.
[21] A. Vitry,et al. Comparative assessment of four drug interaction compendia. , 2007, British journal of clinical pharmacology.
[22] Jos G. W. Kosterink,et al. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis , 2015, J. Am. Medical Informatics Assoc..
[23] Yang Liu,et al. Ease of adoption of clinical natural language processing software: An evaluation of five systems , 2015, J. Biomed. Informatics.
[24] Andrew T Chan,et al. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. , 2015, JAMA.
[25] Lisa Bastarache,et al. Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation , 2019, JMIR Medical Informatics.
[26] B. Reed,et al. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2016, Circulation.
[27] Prakash M. Nadkarni,et al. Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions , 2011, J. Am. Medical Informatics Assoc..
[28] Yen S. Low,et al. Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art , 2014, Drug Safety.
[29] Nigam H. Shah,et al. Mining clinical text for signals of adverse drug-drug interactions , 2014, J. Am. Medical Informatics Assoc..
[30] K. Ryzhikova,et al. Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects , 2019, Pharmacogenomics and personalized medicine.
[31] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[32] M. Schemper,et al. A solution to the problem of separation in logistic regression , 2002, Statistics in medicine.
[33] Joshua C. Denny,et al. Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity , 2015, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[34] J C Denny,et al. Representing Knowledge Consistently Across Health Systems , 2017, Yearbook of Medical Informatics.
[35] David W. Bates,et al. Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records , 2013, BMC Medical Informatics and Decision Making.
[36] Ugo Moretti,et al. Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions , 2012, Expert opinion on drug safety.
[37] Vasa Curcin,et al. Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991–2006 , 2008, PloS one.
[38] Pedro J. Caraballo,et al. Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus , 2012, J. Am. Medical Informatics Assoc..
[39] Patrick B. Ryan,et al. Validation of a common data model for active safety surveillance research , 2012, J. Am. Medical Informatics Assoc..
[40] E. Phillips,et al. The challenge of de‐labeling penicillin allergy , 2020, Allergy.
[41] R. Altman,et al. Detecting Drug Interactions From Adverse‐Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels , 2011, Clinical pharmacology and therapeutics.
[42] Cédrick Fairon,et al. Annotation analysis for testing drug safety signals using unstructured clinical notes , 2012, J. Biomed. Semant..
[43] Suzanne V. Blackley,et al. A dynamic reaction picklist for improving allergy reaction documentation in the electronic health record , 2020, J. Am. Medical Informatics Assoc..
[44] E. Olvey,et al. Comparison of Critical Drug–Drug Interaction Listings: The Department of Veterans Affairs Medical System and Standard Reference Compendia , 2010, Clinical pharmacology and therapeutics.
[45] K. Johnell,et al. The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly , 2007, Drug safety.
[46] Jocelyn R. Wilder,et al. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. , 2016, JAMA internal medicine.
[47] Melissa A. Basford,et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data , 2013, Nature Biotechnology.
[48] R. Altman,et al. Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.
[49] Harry Hochheiser,et al. Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessment , 2020, J. Biomed. Informatics.